Press Releases

Month Year

Month Year

Jul 31, 2013

Insmed to Host Second Quarter 2013 Financial Results Conference Call on Tuesday, August 6, 2013

Read more
Jul 29, 2013

Insmed Appoints Christine Pellizzari as General Counsel and Corporate Secretary

Read more
Jul 22, 2013

Insmed Announces Closing of Public Offering and Exercise of Option to Purchase Additional Shares

Read more
Jul 17, 2013

Insmed Announces Pricing of Public Offering of Common Stock

Read more
Jul 15, 2013

Insmed Announces Proposed Public Offering of Common Stock

Read more
Jul 8, 2013

Insmed to Present at the 8th Annual JMP Securities Healthcare Conference

Read more
Jul 1, 2013

ARIKACE Meets Primary Endpoint of Non-Inferiority to TOBI in Phase 3 Clinical Trial in Europe and Canada to Treat Pseudomonas aeruginosa in Cystic Fibrosis Patients

ARIKACE Receives Qualified Infectious Disease Product and Fast Track Designations from the U.S. FDA for the Treatment of Non-Tuberculous Mycobacteria Lung Infections

Read more
Jun 28, 2013

Insmed to Join the Russell Global(R) and Russell 3000(R) Indexes

Read more
Jun 28, 2013

Insmed to Report Top-Line Results From Phase 3 Clinical Trial of ARIKACE to Treat Pseudomonas Aeruginosa in Cystic Fibrosis

Read more
May 14, 2013

Insmed Granted Key Composition of Matter Patent Allowance for ARIKACE in Europe

Read more

Show per page

Stay In The Loop

Want to stay up to date on our news, events, and filings? Set up your email alerts.

Investor Presentation

View the latest Insmed Investor Presentation